Quoted from http://www.bloomberg.com/news/print/2014-05-28/boehringer-pays-650-million-to-end-blood-thinner-cases.html
Boehringer Pays $650 Million to End Blood Thinner Cases
By Jef Feeley - May 28, 2014
Boehringer Ingelheim GmbH, the German family-owned drugmaker, agreed to pay $650 million to settle the majority of lawsuits filed over its blood-thinning drug Pradaxa, which has been linked to more than 500 patient deaths.
Boehringer, slated to face the first trial in September of claims there was no antidote to stop bleed-out deaths among Pradaxa patients, is seeking to settle about 4,000 suits, company officials said in a statement today. That would provide an average per-case payout of $162,500.
The settlement comes about week after the drugmaker, based in Ingelheim, Germany, said a new analysis of a company-funded study used to win approval of the blood thinner found 22 serious bleeding events that weren’t included in the original report.
[Article continues at original source]